Latest revenue
$75.3M
as of 2026-03-31
Latest net income
$-1.8M
as of 2026-03-31
Net margin
-2.3%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $561.7M
- Enterprise value
- $561.7M
- P/E (trailing)
- 29.4×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $37.77
- 52-wk low
- $9.41
- Beta
- —
- Shares out
- 22.6M
5-year trend
What this company does
Overview Tactile Systems Technology, Inc. (“we,” “us,” and “our”) is a medical technology company that develops and provides innovative medical devices for the treatment of underserved chronic diseases. We were originally incorporated in Minnesota under the name Tactile Systems Technology, Inc. on January 30, 1995. During 2006, we established a merger corporation and subsequently, on July 21, 2006, merged with and into this merger corporation resulting in us being reincorporated as a Delaware corporation. The resulting corporation assumed the name Tactile Systems Technology, Inc. and in September 2013, we began doing business as “Tactile Medical”. Our mission is to help people suffering…
AI summary unavailable — showing raw filing excerpt
Generated from TCMD's filing dated 2026-02-17
Key risks
Item 1A. Risk Factors. Risk factors which could cause actual results to differ from our expectations and which could negatively impact our financial condition and results of operations are discussed below and elsewhere in this report. Additional risks and uncertainties not presently known to us or that are currently not believed to be significant to our business may also affect our actual results and could harm our business, financial condition and results of operations. If any of the risks or uncertainties described below or any additional risks and uncertainties actually occur, our business, results of operations and financial condition could be materially and adversely affected. Risks…
AI summary unavailable — showing raw filing excerpt
Generated from TCMD's filing dated 2026-02-17
Profitability
Gross margin
75.9%
2.6%Operating margin
8.9%
17.4%Net margin
5.8%
0.1%Return on equity
8.7%
11.4%Return on assets
7.0%
22.4%Leverage
Debt / equity
0.25×
33.0%Long-term debt / equity
0.11×
20.7%Debt / assets
20.1%
26.4%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $75.3M | +22.8% | $-1.8M | +40.7% | -2.3% |
Q4 2025 2025-12-31 | $103.6M | +21.0% | $13.6M | +14.1% | 13.1% |
Q3 2025 2025-09-30 | $85.8M | +17.3% | $8.2M | +59.2% | 9.6% |
Q2 2025 2025-06-30 | $78.9M | +7.8% | $243.0K | -88.4% | 0.3% |
Q1 2025 2025-03-31 | $61.3M | +0.3% | $-3.0M | -34.6% | -4.9% |
Q4 2024 2024-12-31 | $85.6M | — | $11.9M | — | 13.9% |
Q3 2024 2024-09-30 | $73.1M | +5.0% | $5.2M | -74.6% | 7.1% |
Q2 2024 2024-06-30 | $73.2M | +7.1% | $2.1M | +2189.0% | 2.9% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Surgical & Medical Instruments & Apparatus · SIC 3841
Your notes
Keep private notes on TCMD — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$1.8M
Net activity
−$1.8M
Distinct insiders
3
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns TCMD
Institutional value
$236.0M
Total shares held
10.4M
Distinct holders
107
-60 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 1.8M | $46.5M | +8.6K (+0.5%) | Added |
| 2 | DIMENSIONAL FUND ADVISORS LP | 1.1M | $28.2M | -15.5K (-1.4%) | Trimmed |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 945.1K | $24.7M | — | New |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 668.3K | $17.5M | — | New |
| 5 | FEDERATED HERMES, INC. | 661.0K | $17.3M | +15.5K (+2.4%) | Added |
| 6 | DEUTSCHE BANK AG\ | 580.8K | $15.2M | +2.1K (+0.4%) | Added |
| 7 | PINNACLE ASSOCIATES LTD | 326.8K | $8.5M | -862 (-0.3%) | Trimmed |
| 8 | UBS Group AG | 223.6K | $5.8M | +25.8K (+13.1%) | Added |
| 9 | GLOBEFLEX CAPITAL L P | 222.3K | $5.8M | -18.9K (-7.9%) | Trimmed |
| 10 | PRUDENTIAL FINANCIAL INC | 222.1K | $5.8M | +171.4K (+337.9%) | Added |
| 11 | Bank of New York Mellon Corp | 150.9K | $3.9M | -13.5K (-8.2%) | Trimmed |
| 12 | VANGUARD FIDUCIARY TRUST CO | 146.8K | $3.8M | — | New |
| 13 | FRANKLIN RESOURCES INC | 136.9K | $3.6M | +90.8K (+197.1%) | Added |
| 14 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 132.0K | $3.4M | +53.0K (+67.0%) | Added |
| 15 | Invesco Ltd. | 121.3K | $3.2M | -39.0K (-24.4%) | Trimmed |
| 16 | Accredited Investors Inc. | 94.9K | $2.5M | -20.5K (-17.7%) | Trimmed |
| 17 | Kopp Family Office, LLC | 85.0K | $2.2M | -42.3K (-33.2%) | Trimmed |
| 18 | BURNEY CO/ | 78.9K | $2.1M | — | New |
| 19 | SummerHaven Investment Management, LLC | 78.6K | $2.1M | -3.9K (-4.8%) | Trimmed |
| 20 | Integrated Quantitative Investments LLC | 76.0K | $2.0M | +42.4K (+126.0%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once TCMD's latest filing finishes processing.